
Brian E. Mcdowell
Examiner (ID: 2181, Phone: (571)270-5755 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 4161, 1624 |
| Total Applications | 1622 |
| Issued Applications | 1025 |
| Pending Applications | 135 |
| Abandoned Applications | 522 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19367420
[patent_doc_number] => 12059481
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-13
[patent_title] => Compounds, systems, and methods for monitoring and treating a surface of a subject
[patent_app_type] => utility
[patent_app_number] => 17/583997
[patent_app_country] => US
[patent_app_date] => 2022-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 22
[patent_no_of_words] => 14385
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17583997
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/583997 | Compounds, systems, and methods for monitoring and treating a surface of a subject | Jan 24, 2022 | Issued |
Array
(
[id] => 19884145
[patent_doc_number] => 12269837
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-08
[patent_title] => Bifunctional do2pa derivatives, chelates with metallic cations and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/648688
[patent_app_country] => US
[patent_app_date] => 2022-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10898
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 235
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17648688
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/648688 | Bifunctional do2pa derivatives, chelates with metallic cations and use thereof | Jan 23, 2022 | Issued |
Array
(
[id] => 17578672
[patent_doc_number] => 20220135527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => PROCESSES FOR PREPARING ASK1 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/579497
[patent_app_country] => US
[patent_app_date] => 2022-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26669
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17579497
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/579497 | PROCESSES FOR PREPARING ASK1 INHIBITORS | Jan 18, 2022 | Abandoned |
Array
(
[id] => 17578672
[patent_doc_number] => 20220135527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => PROCESSES FOR PREPARING ASK1 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/579497
[patent_app_country] => US
[patent_app_date] => 2022-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26669
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17579497
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/579497 | PROCESSES FOR PREPARING ASK1 INHIBITORS | Jan 18, 2022 | Abandoned |
Array
(
[id] => 18987709
[patent_doc_number] => 20240059678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => Synthesis Method for Aminopyrimidine FAK Inhibitor Compound
[patent_app_type] => utility
[patent_app_number] => 18/261057
[patent_app_country] => US
[patent_app_date] => 2022-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4140
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18261057
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/261057 | Synthesis Method for Aminopyrimidine FAK Inhibitor Compound | Jan 17, 2022 | Pending |
Array
(
[id] => 17578719
[patent_doc_number] => 20220135574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => BIARYL DERIVATIVE AS GPR120 AGONIST
[patent_app_type] => utility
[patent_app_number] => 17/577139
[patent_app_country] => US
[patent_app_date] => 2022-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 126495
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 970
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17577139
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/577139 | BIARYL DERIVATIVE AS GPR120 AGONIST | Jan 16, 2022 | Pending |
Array
(
[id] => 17734634
[patent_doc_number] => 20220220093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => CRYSTALLINE FORMS OF N-(4-(4-(CYCLOPROPYLMETHYL)PIPERAZINE-1-CARBONYL)PHENYL)QUINOLINE-8-SULFONAMIDE
[patent_app_type] => utility
[patent_app_number] => 17/575898
[patent_app_country] => US
[patent_app_date] => 2022-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28203
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17575898
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/575898 | CRYSTALLINE FORMS OF N-(4-(4-(CYCLOPROPYLMETHYL)PIPERAZINE-1-CARBONYL)PHENYL)QUINOLINE-8-SULFONAMIDE | Jan 13, 2022 | Pending |
Array
(
[id] => 19624014
[patent_doc_number] => 12162818
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-10
[patent_title] => Inhibitors of the n-terminal domain of the androgen receptor
[patent_app_type] => utility
[patent_app_number] => 17/575027
[patent_app_country] => US
[patent_app_date] => 2022-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 16
[patent_no_of_words] => 36164
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17575027
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/575027 | Inhibitors of the n-terminal domain of the androgen receptor | Jan 12, 2022 | Issued |
Array
(
[id] => 17776503
[patent_doc_number] => 20220242852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 17/570936
[patent_app_country] => US
[patent_app_date] => 2022-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29982
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 1059
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17570936
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/570936 | Compounds and compositions for treating conditions associated with STING activity | Jan 6, 2022 | Issued |
Array
(
[id] => 17563117
[patent_doc_number] => 20220127266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => MALIC ENZYME INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/646897
[patent_app_country] => US
[patent_app_date] => 2022-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29540
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17646897
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/646897 | MALIC ENZYME INHIBITORS | Jan 3, 2022 | Abandoned |
Array
(
[id] => 19003562
[patent_doc_number] => 20240067633
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => KETOHEXOKINASE INHIBITOR AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/269494
[patent_app_country] => US
[patent_app_date] => 2021-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27139
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 995
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18269494
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/269494 | KETOHEXOKINASE INHIBITOR AND USE THEREOF | Dec 20, 2021 | Pending |
Array
(
[id] => 19020116
[patent_doc_number] => 20240076287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => SOLID FORMS OF A CDK2 INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 18/268959
[patent_app_country] => US
[patent_app_date] => 2021-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19660
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18268959
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/268959 | SOLID FORMS OF A CDK2 INHIBITOR | Dec 20, 2021 | Pending |
Array
(
[id] => 17734663
[patent_doc_number] => 20220220122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => PCSK9 INHIBITORS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/555729
[patent_app_country] => US
[patent_app_date] => 2021-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69574
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17555729
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/555729 | PCSK9 INHIBITORS AND METHODS OF USE THEREOF | Dec 19, 2021 | Pending |
Array
(
[id] => 19020108
[patent_doc_number] => 20240076279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => NOVEL BENZOAZEPINE COMPOUND, AND COMPOSITION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/271523
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10127
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 173
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18271523
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/271523 | NOVEL BENZOAZEPINE COMPOUND, AND COMPOSITION AND USE THEREOF | Dec 16, 2021 | Pending |
Array
(
[id] => 18101166
[patent_doc_number] => 11541034
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-03
[patent_title] => Nitrile-containing antiviral compounds
[patent_app_type] => utility
[patent_app_number] => 17/554091
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 70721
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17554091
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/554091 | Nitrile-containing antiviral compounds | Dec 16, 2021 | Issued |
Array
(
[id] => 17720327
[patent_doc_number] => 20220213047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => CARBONIC ANHYDRASE INHIBITORS FOR TREATMENT OF NEISSERIA GONORRHOEAE INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/552413
[patent_app_country] => US
[patent_app_date] => 2021-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11539
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17552413
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/552413 | CARBONIC ANHYDRASE INHIBITORS FOR TREATMENT OF NEISSERIA GONORRHOEAE INFECTION | Dec 15, 2021 | Pending |
Array
(
[id] => 18971878
[patent_doc_number] => 20240051970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 18/266156
[patent_app_country] => US
[patent_app_date] => 2021-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33959
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 1004
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18266156
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/266156 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | Dec 15, 2021 | Pending |
Array
(
[id] => 18971878
[patent_doc_number] => 20240051970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 18/266156
[patent_app_country] => US
[patent_app_date] => 2021-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33959
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 1004
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18266156
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/266156 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | Dec 15, 2021 | Pending |
Array
(
[id] => 19112668
[patent_doc_number] => 20240124418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => PDE4 DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 18/256636
[patent_app_country] => US
[patent_app_date] => 2021-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60621
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -153
[patent_words_short_claim] => 601
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18256636
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/256636 | PDE4 DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS | Dec 12, 2021 | Pending |
Array
(
[id] => 17505066
[patent_doc_number] => 20220098168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => METHODS AND COMPOSITIONS FOR SCREENING AND IDENTIFICATION OF SPLICING MODULATORS
[patent_app_type] => utility
[patent_app_number] => 17/549241
[patent_app_country] => US
[patent_app_date] => 2021-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39903
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 287
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17549241
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/549241 | METHODS AND COMPOSITIONS FOR SCREENING AND IDENTIFICATION OF SPLICING MODULATORS | Dec 12, 2021 | Abandoned |